Connect with us

Technology

Clarium Raises $27M Series A to Scale AI-Powered Supply Chain Resiliency Technology to Leading Health Systems

Published

on

Amid global supply chain volatility, Yale, Stanford, and Kaiser Permanente build resilient healthcare supply networks powered by Clarium

NEW YORK, May 8, 2025 /PRNewswire/ — Clarium, the company powering the world’s first and market-leading AI-powered healthcare supply chain resiliency platform, today announced a $27 million Series A funding round from Northzone, with participation from existing investors including General Catalyst, AlleyCorp, Kaiser Permanente Ventures, Texas Medical Center Ventures, and 1984 Ventures. This round brings Clarium’s total funding to $43 million to-date, and will allow the company to deliver on its mission of optimizing the modern health system and mitigating growing economic and environmental uncertainty in the supply chain for suppliers and hospitals.

The healthcare industry overspends on its supply chain by over $25B each year, largely due to fragmented, unharnessed data, inefficient workflows, and wasted supplies. As major weather events, global pandemics, and economic tariffs intensify, supply chain vulnerabilities are poised to disrupt critical care operations in hospitals nationwide.

Clarium’s platform collects, unifies, and automates crowdsourced data from providers, suppliers, and vendors across the entire healthcare supply chain, creating the world’s first AI-powered resiliency platform dedicated to helping major hospitals and health systems manage their supply chain operations. Clarium predicts supply chain disruptions based on real-time weather, geopolitical, and current events data, providing tailored recommendations for substitutions and preventing major disruptions to productivity and outcomes. The resiliency platform – which spans workflow operations, inventory and stock management, and disruption and substitution optimization – are ideated and built in collaboration with leading health systems, allowing Clarium to respond swiftly and directly to the needs of supply chain teams. After adopting Astra OS, hospital systems have seen over $10 million in average cost savings, fueled by 50% faster disruption resolution and 88% substitute approvals.

“The fragmentation and inefficiencies of the healthcare supply chain continue to plague our country’s hospital systems as they face more financial pressure than ever,” said Steve Liou, Founder and CEO of Clarium. “At Clarium, we’re leveraging the power of AI to modernize the hospital supply chain, working directly with health systems to develop valuable technology that enhances productivity, cuts wasteful spend, and improves patient health outcomes. We are grateful for the support from Northzone and our existing investors as we continue scaling our platform to new partners across the country.”

“Working closely with Clarium has allowed us to access the next-gen technology we need to manage our supply chain more efficiently,” said Jacqueline Epright, Chief Supply Chain Officer at Yale New Haven Health. “Clarium is innovative to address supply chain pain points, attuned to our needs, and truly dedicated to helping our hospital systems save on costs and deliver the best possible health outcomes to patients.”

Clarium’s $27 million financial investment from Northzone and existing partners will allow the company to accelerate the development and scale of Astra OS – including additional app and solution development – expand its team, and develop relationships with new health system partners.

“Despite many recent advancements in healthcare technology, hospital procurement processes have largely remained stuck in the 20th century. While several point solutions exist, Clarium is the first comprehensive, end-to-end platform for managing the hospital supply chain,” said Molly Alter, Partner at Northzone. “We believe Clarium possesses the technology and vision to enable end-to-end supply chain management for every one of the 5,000 hospitals nationwide.”

Since announcing its seed funding in 2024, Clarium has doubled its headcount and added key leadership including Burton Bracken (Head of Business Development), Marek Sirendi (Head of AI), Marcelo Fracchia (VP of Growth), and Shivani Stadvec (Chief Marketing Officer). The company has also expanded its collaborators roster beyond Yale New Haven Health, Geisinger, Ochsner Health, and Boston Children’s Hospital to include The Cleveland Clinic, Kaiser Permanente, Sutter Health, St. Luke’s, and others. Additionally, Clarium announced a long-term strategic partnership with the Healthcare Industry Resiliency Collaborative (HIRC) to co-develop transformative technology and data standards.

To learn more about Clarium and its technology, visit www.clariumhealth.com.

About Clarium
Clarium is a healthcare technology company that is transforming how the hospital supply chain is managed for providers and suppliers. Clarium empowers leading health systems, including Yale New Haven Health, Stanford, and Geisinger, to optimize their supply chain operations with an AI-powered platform, Astra OS, which delivers unified data, actionable insights, and intelligent workflow automation. The company was founded in 2020 by Steve Liou and has raised $43 million in venture funding.

About Northzone
Northzone (northzone.com) is a global venture capital fund built on experience spanning multiple economic and disruptive technology cycles. Founded in 1996, Northzone has raised more than ten funds to date, with its most recent fundraise in excess of $1.2 billion and has invested in more than 175 companies, including category-defining businesses such as Trustpilot, Spotify, Klarna, iZettle, Kahoot!, Personio, TrueLayer, Spring Health, and Zopa.

Northzone is a full-stack investor from Seed to Growth stage, with transatlantic hubs out of London, New York, Amsterdam, Berlin, Stockholm and Oslo.

View original content to download multimedia:https://www.prnewswire.com/news-releases/clarium-raises-27m-series-a-to-scale-ai-powered-supply-chain-resiliency-technology-to-leading-health-systems-302450625.html

SOURCE Clarium

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

iFOREX Lists on London Stock Exchange, Supporting Focus Across Global and Indian Markets

Published

on

By

LONDON, April 17, 2026 /PRNewswire/ — iFOREX today announced its recent admission to the Main Market of the London Stock Exchange (LSE) under the ticker IFRX, at a market valuation of approximately £43.3 million. This milestone marks a significant step in the Company’s long-term growth strategy and supports its continued expansion across international markets, including a growing focus on India.

With over 30 years of experience in the online trading industry, iFOREX has established a strong global presence built on proprietary technology, consistent innovation, and disciplined risk management. The Company continues to deliver advanced trading solutions alongside a high standard of client support, designed to meet the evolving needs of retail traders in dynamic markets.

Through its proprietary web-based and mobile trading platforms, iFOREX provides access to over 900 financial instruments, including foreign exchange, commodities, indices, stocks, cryptocurrencies, and ETFs. The Company continuously enhances its technology and product offering to deliver a seamless, secure, and efficient trading experience for its global client base.

India represents an increasingly important market for iFOREX, supported by a rapidly growing base of digitally engaged traders and rising interest in global financial markets. The Company aims to strengthen its presence by offering localized support, tailored educational resources, and technology-driven solutions aligned with the needs of Indian traders.

The Company’s admission to the London Stock Exchange enhances its visibility and credibility as a global fintech provider, focusing on investing in platform development, optimizing client experience, and scaling its international operations to support long-term growth.

“Our listing on the London Stock Exchange represents an important milestone in iFOREX’s evolution as a global trading provider,” said Itai Sadeh, Chief Executive Officer of iFOREX. “We see significant potential in the Indian market, driven by strong demand for digital trading solutions and increasing participation in global markets. We remain committed to expanding our presence in India while continuing to invest in technology, innovation, and client experience.”

iFOREX will continue to monitor market developments, adapt its offering to the needs of traders across different regions, and focus on delivering reliable services, transparent trading conditions, and long-term value to its clients and stakeholders.

Find out more here: iFOREX Website

This press release is intended solely for media use. It is not meant for individual investors and does not contain personal advice or recommendations.

 

View original content:https://www.prnewswire.com/in/news-releases/iforex-lists-on-london-stock-exchange-supporting-focus-across-global-and-indian-markets-302755696.html

Continue Reading

Technology

iFOREX Lists on London Stock Exchange, offering Cryptocurrency trading (CFDs) Across Global and LATAM Markets

Published

on

By

LONDON, April 29, 2026 /PRNewswire/ — iFOREX today announced its admission to the Main Market of the London Stock Exchange (LSE) under the ticker IFRX, with a market valuation of approximately £43.3 million. This milestone represents a major step in the Company’s global growth strategy and supports its continued expansion across international markets, including cryptocurrency CFD trading for retail investors in Latin America (LATAM) and beyond.

The listing underscores iFOREX’s commitment to combining traditional financial instruments with the evolving opportunities presented by the cryptocurrency market. Over the past decade, iFOREX has offered retail traders access to a broad portfolio of crypto CFDs, including Bitcoin (BTC), Ethereum (ETH), Ripple (XRP), Litecoin (LTC), and a growing range of other digital assets, alongside forex, commodities, indices, equities, and ETFs. The Company’s proprietary online and mobile platforms allow traders to seamlessly navigate both crypto and traditional markets from a single interface.

With more than 25 years of experience in online trading, iFOREX has built a solid global presence based on proprietary technology, disciplined risk management, and continuous innovation. By integrating crypto trading alongside traditional instruments, the Company provides traders with diversified opportunities, enhanced liquidity, and sophisticated tools to manage risk and capitalize on market trends.

Latin America represents a particularly high-growth region for cryptocurrency trading, supported by increasing digital adoption, rising interest in global financial markets, and a growing number of self-directed retail investors. iFOREX is committed to strengthening its presence in the region by offering localized services, multilingual support, and educational resources specifically designed to help LATAM clients engage confidently with both crypto and forex markets.

The LSE listing enhances iFOREX’s credibility and visibility as a global fintech provider while supporting its strategy to expand crypto trading offerings, scale operations, and provide long-term value to clients and shareholders. The Company continues to focus on platform innovation, regulatory compliance, and the development of tools that allow traders to execute informed and secure transactions across all available markets.

Itai Sadeh, Chief Executive Officer of iFOREX, commented:

“Our admission to the Main Market of the London Stock Exchange represents a landmark moment for iFOREX and reflects our commitment to innovation in financial trading, including cryptocurrencies. Latin America presents strong growth potential in digital assets, and we are focused on providing robust, reliable platforms, localized education, and tools that empower traders to access opportunities across both crypto and traditional markets.”

Looking forward, iFOREX plans to expand its crypto product offering, explore emerging digital asset trends, and continue delivering a secure, innovative, and client-focused trading experience to retail investors worldwide.

 

View original content:https://www.prnewswire.co.uk/news-releases/iforex-lists-on-london-stock-exchange-offering-cryptocurrency-trading-cfds-across-global-and-latam-markets-302755709.html

Continue Reading

Technology

Temu and QIMA Partner to Strengthen Product Testing and Platform Compliance

Published

on

By

DUBLIN, April 29, 2026 /PRNewswire/ — Temu, the global e-commerce platform, and QIMA, a leading testing, inspection, and certification company, today announced a partnership to strengthen product compliance and safety across the Temu platform. Under the partnership, QIMA’s testing and certification services will be integrated directly into Temu’s Seller Center, making compliance resources accessible to sellers.

QIMA will deliver independent product testing, on-site factory inspections, seller training programs, and digital compliance tools. Product testing will cover four initial categories: electrical and electronic goods, jewelry and gemstones, food contact materials, and light industrial products. Testing will be conducted against applicable regulatory and safety standards. QIMA will also conduct on-site factory inspections for selected sellers to verify production processes and supply chain practices at the source.

The Temu-QIMA partnership also includes structured training programs designed to help sellers better understand testing standards and regulatory requirements across markets, along with regular roundtables and workshops on evolving rules, policy developments, and compliance approaches.

“As e-commerce platforms serve more markets and more product categories, independent compliance infrastructure becomes essential, not optional,” said Pierre-Nicolas Disser, CEO of Consumer Products, QIMA. “This partnership, and particularly the integration into Temu’s Seller Center, is a step toward making compliance testing and certification a routine part of how sellers operate. That’s exactly the kind of work QIMA’s global network was built for.”

The partnership with QIMA builds on Temu’s broader product safety and compliance program. In 2025, the company invested approximately US$100 million globally in compliance, product safety, and quality control, with plans to double that investment in 2026. To date, Temu has established cooperation with more than 60 independent testing institutions worldwide. The partnership with QIMA represents one of the first integration of third-party compliance tools directly into the Temu Seller Center workflow.

“Temu prioritizes the safety of products on our platform, and our partnership with QIMA is a concrete step in that direction,” said a Temu spokesperson. “Together with QIMA, we are focused on providing consumers with a safe and trustworthy shopping experience, while making compliance resources more accessible to sellers on our platform.”

About Temu

Temu is a global e-commerce platform connecting consumers with millions of manufacturers, brands, and business partners. Operating in more than 90 markets worldwide, Temu is committed to providing affordable, high-quality products that enable customers to live better lives.

About QIMA

At QIMA, we are on a mission to help our clients make products consumers can trust. We have developed compliance solutions for testing, inspection and certification (TIC) that enable supply chain agility, sustainability, and product innovation. Our services are used by 30,000 businesses globally in the consumer products, agri-food and life sciences industries. What truly sets us apart is our unique culture of relentless care for our clients, and a commitment to offering intuitive solutions that blend deep tech and human intelligence; this is how QIMA continues to disrupt the Testing, Inspection and Certification industry.

SOURCE Temu

Continue Reading

Trending